National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01FX04	YERVOY	BioTech	Ipilimumab - 50mg/10ml	50mg/10ml	Injectable solution	332,262,937 L.L
B05AA07	VOLUVEN	B	Starch poly(O-2-Hydroxyethyl) - 6%	6%	Injectable solution	987,724 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	176,974 L.L
C07AG01	LABETALOL HYDROCHLORIDE INJECTION	G	Labetalol HCl - 100mg/20ml	100mg/20ml	Injectable solution	2,955,110 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 10mg/0.2ml	10mg/0.2ml	Injectable solution	1,553,482 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	137,902 L.L
G02AX	OXYTOCIN 10 PANPHARMA 10 UI-1ML	G	Oxytocin - 10IU/ml	10IU/ml	Injectable solution	525,442 L.L
L04AX03	EBETREXAT	G	Methotrexate - 15mg/1.5ml	15mg/1.5ml	Injectable solution	2,135,366 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	355,798 L.L
B05BA01	AMINOVEN INFANT	B	L-Leucine - 13g/l, L-Isoleucine - 8g/l, L-Lysine Acetate - 12g/l, L-Methionine - 3.12g/l, L-Phenylalanine - 3.75g/l, L-Threonine - 4.40g/l, L-Tryptophan - 2.01g/l, L-Valine - 9g/l, Arginine - 7.5g/l, L-Histidine - 4.76g/l, Glycine - 4.15g/l, L-Taurine - 0.40g/l, L-Serine - 7.67g/l, L-Alanine - 9.3g/l, L-Proline - 9.71g/l, N-Acetyl-L-Tyrosine - 5.176g/l, N-Acetyl-L-Cysteine - 0.70g/l, L-Malic Acid - 2.62g/l	10%	Injectable solution	880,217 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	155,139 L.L
G02AX	OXYTOCIN 10 PANPHARMA 10 UI-1ML	G	Oxytocin - 10IU/ml	10IU/ml	Injectable solution	525,442 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 15mg/0.3ml	15mg/0.3ml	Injectable solution	1,968,729 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	2,557,140 L.L
B05BA01	AMINOPLASMAL B. BRAUN	B	Amino acids - 10%	10%	Injectable solution	1,036,103 L.L
B05XA03	HYPOTONIC SALINE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 20mg/0.4ml	20mg/0.4ml	Injectable solution	2,134,022 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable solution	37,110,724 L.L
A03BB01	SCOBUREN	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	370,901 L.L
B05XA03	HYPOTONIC SALINE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	163,184 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 10mg/ml	10mg/ml	Injectable solution	95,166,436 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 25mg/0.5ml	25mg/0.5ml	Injectable solution	2,582,865 L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	214,213,273 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	178,731 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	133,856 L.L
L01CA02	CELLCRISTIN	G	Vincristine sulfate - 1mg/ml	1mg/ml	Injectable solution	1,166,025 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 90mg/ml	90mg/ml	Injectable solution	483,720,518 L.L
A03BB01	? HYOSCINE BUTYLBROMIDE	G	Hyoscine butylbromide - 20mg/ml	20mg/ml	Injectable solution	70,392 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L

National Cancer Registry (NCR)